-
Product Insights
Likelihood of Approval Analysis for Acute Heart Failure
Overview How likely is it that the drugs in Acute Heart Failure will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Heart Failure Overview Acute heart failure (AHF) is a critical...
-
Analyst Opinions
Adaptogens in Non-Alcoholic Beverages – Industry Insights
Adaptogens in Non-Alcoholic Beverages Industry Report Overview Adaptogens have gained popularity among global audiences due to the wide range of functionalities they provide. To stand out in the market, attract new groups of consumers, and differentiate products from the competitors' offers, brands operating in the market for non-alcoholic beverages (NABs) often incorporate new ingredients. One of the ingredient groups that is rapidly gaining popularity is adaptogens. Adaptogens are synthetic or plant-based substances that are claimed to support stress management, anxiety-easing,...
-
Analyst Opinions
Advanced Barrier Packaging – Industry Insights
Reasons to buy the ‘Advanced Barrier Packaging’ industry insight report: The report is driven by GlobalData's Mega-trend Survey Analysis, primary consumer research that periodically compares the magnitude of each trend and its impact on consumer behavior. Understand the eight mega-trends, namely health & wellness, sensory & indulgence, sustainability & ethics, digitalization, individualism & expression, easy & affordable, comfort & uncertainty, and demographics, and their impact on consumer purchasing behavior. The outcomes of the survey allow us to determine the extent...
-
Sector Analysis
Guided Health – Consumer TrendSights Analysis, 2023
Guided Health - Consumer TrendSights Report Overview In the information economy, health-conscious consumers now more confidently embrace an abundance of new information tools, enabling more informed health-driven choices. It is, therefore, important for brands to offer health guidance for consumers who wish to self-medicate more often. This growing consumer health demand demonstrates the opportunity for brands to offer personalized digitally-driven healthcare solutions through the product purchase journey. TrendSights: Guided Health Buy the Full Report for More Insights into the Guided...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – STA-363 in Chronic Low Back Pain (CLBP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - STA-363 in Chronic Low Back Pain (CLBP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. STA-363 in Chronic Low Back Pain (CLBP) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – InCVAX in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - InCVAX in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. InCVAX in Colorectal Cancer Drug Details: inCVAX is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – InCVAX in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - InCVAX in Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. InCVAX in Melanoma Drug Details: inCVAX is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – InCVAX in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - InCVAX in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. InCVAX in Solid Tumor Drug Details: inCVAX is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – InCVAX in Soft Tissue Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - InCVAX in Soft Tissue Sarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. InCVAX in Soft Tissue Sarcoma Drug Details: inCVAX is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BEAM-101 in Beta Thalassaemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BEAM-101 in Beta Thalassaemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BEAM-101 in Beta Thalassaemia Drug Details: BEAM-101 is under development for the...